23 January 2025
BIOPHARMA
CREDIT PLC
("BIOPHARMA CREDIT" OR THE "COMPANY")
ORDINARY
AND SPECIAL DIVIDEND DECLARATION
2.89
CENT PER SHARE DISTRIBUTION INCLUDING A 1.14
CENT SPECIAL DISTRIBUTION
BioPharma Credit PLC (LSE: BPCR),
the specialist life sciences debt investor, is pleased to declare
an interim dividend in respect of the quarterly financial period
ending 31 December 2024 of 2.892309 cents per share, payable on 28
February 2025 to ordinary shareholders on the register as at 31
January 2025. The 2.892309 cents dividend comprises an ordinary dividend of 1.75
cents and a special dividend of 1.142309 cents. The ex-dividend date will be 30
January 2025.
The Company is currently paying and
continues to target a 7-cent base annual dividend per ordinary
share. After the payment of the dividend on 28 February 2025,
dividends for the calendar year 2024 to date will total 10.18
cents.
The Company has chosen to designate
the entire amount of this interim dividend as an interest
distribution. Shareholders in receipt of such a dividend will be
treated for UK tax purposes as though they have received a payment
of interest. This will result in a reduction in the corporation tax
payable by the Company.
The default payment for dividends is
in US dollars. However, shareholders can elect to have dividends
paid in sterling (GBP) and the option to elect a sterling dividend
payment for this dividend will be available to shareholders until
31 January 2025 (the "Election Date").
Further details together with a copy
of the Dividend Currency Election Form, which should be sent to
Link Group, 10th Floor, Central
Square, 29 Wellington Street, Leeds LS1 4DL when
completed, will be available on the Group's website shortly
at www.bpcruk.com/investor-materials.
CREST shareholders must elect via CREST. Further details together
with a copy of the Dividend Currency Election Form, which should be
sent to Link Group, 10th Floor, Central Square, 29
Wellington Street, Leeds LS1 4DL when completed, will be
available on the Group's website shortly
at www.bpcruk.com/investor-materials.
CREST shareholders must elect via CREST.
Enquiries:
BioPharma Credit plc
via MUFG Corporate
Markets
Company Secretary
+44 (0) 1392 477 500
Burson Buchanan
Mark Court / Jamie
Hooper / Henry Wilson / Samuel Adams
+44 (0) 20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's
only listed specialist investor in debt from the life sciences
industry and joined the LSE on 27 March 2017. The Company seeks to
provide long-term shareholder returns, principally in the form of
sustainable income distributions from exposure to the life sciences
industry. The Company seeks to achieve this objective primarily
through investments in debt assets secured by royalties or other
cash flows derived from the sales of approved life sciences
products.
LEI: 213800AV55PYXAS7SY24
